Compare CCRN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCRN | EOLS |
|---|---|---|
| Founded | 1986 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.1M | 284.3M |
| IPO Year | 2001 | 2018 |
| Metric | CCRN | EOLS |
|---|---|---|
| Price | $9.50 | $4.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $14.15 | ★ $15.50 |
| AVG Volume (30 Days) | 547.2K | ★ 1.5M |
| Earning Date | 03-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $816,484,000.00 | $297,176,000.00 |
| Revenue This Year | N/A | $13.37 |
| Revenue Next Year | $4.93 | $17.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $7.43 | $4.09 |
| 52 Week High | $15.30 | $12.51 |
| Indicator | CCRN | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 33.01 |
| Support Level | $7.68 | N/A |
| Resistance Level | $10.28 | $4.99 |
| Average True Range (ATR) | 0.40 | 0.25 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 46.49 | 2.33 |
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.